Figure 3From: Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical studyLI85008F increases in serum Adiponectin. Bar diagram represents the serum adiponectin concentration (mean ± SE) of subjects supplemented with LI85008F and placebo at the baseline and after 8 weeks. At the end of the study, LI85008F confers significant (p = 0.012) increase in adiponectin level in comparison with placebo (A). Bar diagram indicates comparative increase in serum adiponection concentration of placebo and LI85008F supplemented subjects after 8 weeks in comparison with the baseline (B).Back to article page